PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Analyze analyst forecasts for the company and compare them with competitors.
9.68M
Worse than ADAP's estimated revenue of 49.25M.
-1.93M
Better than ADAP's estimated ebitda of -42.31M.
-1.38
Worse than ADAP's estimated eps of -0.09.
-41.62M
Worse than ADAP's estimated net income of -22.20M.
-1.93M
Better than ADAP's estimated ebit of -42.93M.
358.54M
Worse than ADAP's estimated sg&a expense of 244.98M.
Analyze DCF forecasts for the company and compare them with competitors.
1.03M
Worse than ADAP's revenue of 27.15M.
-9.97%
Worse than ADAP's revenue growth rate of 341.50%.
-33.41M
Better than ADAP's ebitda of -155.59M.
-3243.20%
Worse than ADAP's ebitda margin of -573.13%.
-34.10M
Better than ADAP's ebit of -161.66M.
-3311.07%
Worse than ADAP's ebit margin of -595.49%.
699.00K
Better than ADAP's depreciation of 6.07M.
108.91M
Worse than ADAP's total cash of 204.60M.
10573.79%
Better than ADAP's cash as percentage of revenue of 753.67%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
10.13M
Worse than ADAP's accounts payable of 4.75M.
983.50%
Worse than ADAP's payables as percentage of revenue of 17.51%.
-366.00K
Worse than ADAP's capital expenditure of -29.74M.
-35.53%
Worse than ADAP's capex as percentage of revenue of -109.55%.
4.99%
Better than ADAP's weighted average cost of capital (wacc) of 6.28%.
5.02%
Better than ADAP's cost of equity of 17.51%.
4.08%
Better than ADAP's cost of debt of 4.51%.
-0.23
Better than ADAP's beta of 2.85.
30.07M
Better than ADAP's diluted shares outstanding of 42.05M.
1.57M
Better than ADAP's total debt of 74.21M.
49.31M
Better than ADAP's total equity of 11.69M.
50.89M
Worse than ADAP's total capital of 85.89M.
3.09%
Better than ADAP's debt weighting of 86.40%.
96.91%
Better than ADAP's equity weighting of 13.60%.
-32.98M
Better than ADAP's ebiat of -164.14M.
-28.05M
Better than ADAP's unlevered free cash flow of -198.39M.
2.00%
Equal to ADAP's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Better than ADAP's net debt of -16.93M.
71.33M
Better than ADAP's equity value of -75.14B.
2.37
Better than ADAP's equity value per share of -1786.98.
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.